Publication | Open Access
Characterization and Comparison of GITR Expression in Solid Tumors
59
Citations
36
References
2019
Year
Human tumor data suggest that NSCLC, renal cell carcinoma, and melanoma should be the tumor subtypes prioritized for anti-GITR therapy development.
| Year | Citations | |
|---|---|---|
Page 1
Page 1